维普中文期刊产品整合服务
40篇 您的检索式:作者名="MONTAGNANI F"
    题名 作者 年代 出处 被引量
1Discovery of new My- coplasma pneumoniae antigens by use of a whole - genome lambda dis- play library 显示文摘Beghetto E De Paolis F Montagnani F 2009Microbes Infect2009,11,1:1
2Use of recombi- nant chimeric antigens for the serodiagnosis of Mycoplasma pneumoniae infection显示文摘Montagnani F De Paolis F Beghetto E 2010Clin Microbiol Infect Dis2010,29,11:1
3Microbiological features of acute bacterial conjunctivitis in a central Italian area显示文摘MONTAGNANI F MA LANDRIN IA STOLZUOLI L 2008New Microbiol2008,31,2:1
4Mitochandria and reactive oxygen species显示文摘ADDABBO F MONTAGNANI M GOLIGORSKY MS 2009Hypertension2009,53,6:1
5Effectiveness and safety of oxaliplatin compared to cisplatin for advanced,unresectable gastric cancer: a systematic review and meta-analysis 显示文摘Montagnani F Turrisi G Marinozzi C 2011Gastric Cancer2011,14,1:1
6Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresect- able gastric cancer: a systematic review and meta-analysis 显示文摘Montagnani F Turrisi G Marinozzi C 2011Gastric Cancer2011,14,1:1
7Effectiveness and safety of oxaliplatin compared to cisplatin foradvanced,unresectable gastric cancer:a systematic review and meta-analysis显示文摘Montagnani F Turrisi G Marinozzi C 0,,:1
8Vascular actions of insulin with implications for endothelial dysfunction 显示文摘Potenza MA Addabbo F Montagnani M 2009Am J Physiol Endoerinol Metab2009,297,3:1
9A systematic review of FOLFOXIRI chemotherapy for the first-line treatment of metastatic colorectal cancer:improved efficacy at the cost of increased toxicity显示文摘Montagnani F Chiriatti A Turrisi G 2011Colorectal Dis2011,13,:1
10Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresect-able gastr- ic cancer: a systematic review and rneta-analysis 显示文摘Montagnani F Turrisi G Marinozzi C 2011Gastric Cancer2011,14,1:1
11Vascular actions of insulin with implications for endothelial dysfunction显示文摘Potenza MA Addabbo F Montagnani M 2009Am J Physiol Endocrinol Metab2009,297,3:1
12Clinical ef- ficacy and effectiveness of ursodeoxycholic acid in chol- estatic liver diseases显示文摘Festi D Montagnani MA zzaroli F 2007Curr Clin Pharmacol2007,2,2:1
13Mitochondria and reactive oxygen species 显示文摘Addabbo F Montagnani M Goligorsky MS 2009Hypertension2009,53,6:1
14Use tff recombi- nant chimeric antigens for the serodiagnosis of Myeoplasma pneumoniae infection显示文摘Montagnani F De Paolis F Beghetto E 2010Clin Microbiol Infect Dis2010,29,11:1
15Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liv- er diseases 显示文摘Festi D Montagnani M Azzaroli F 2007Curr Clin Pharmaol2007,2,2:1
16Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gas- tric cancer: a systematic review and meta-analysis显示文摘Montagnani F Turrisi G Marinozzi C 2011Gastric Can- cer2011,14,1:1
17Use of recombi- nant chimeric antigens for the serodiagnosis of myeoplasma pneu- moniae infection 显示文摘Montagnani F De Paolis F Beghetto E 2010Eur J Clin Microbial2010,29,11:1
18Pmarg-Pearlin is a Matrix Protein Involved in Nacre Framework Formation in the Pearl Oyster Pinctada margaritifera 显示文摘Montagnani C Marie B Marin F 2011Chembiochem2011,12,13:1
19Garganose of recombinant chimeric antigens for the serodiagnosis of Mycoplasma pneumoniae infection显示文摘Montagnani F Paolis E Beghetto N 0,,01:1
20Effectiveness andsafety of oxaliplatin compared to cisplatin for advanced, unresect-able gastric cancer: a systematic review and meta-analysis 显示文摘Montagnani F Turrisi G Marinozzi C 2011Gastric Cancer2011,14,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费